Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction
- 30 April 2006
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 185 (2), 421-425
- https://doi.org/10.1016/j.atherosclerosis.2005.06.025
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cardiovascular risk factors and endothelial dysfunctionClinical Science, 2004
- Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Fenofibrate increases the l-arginine:ADMA ratio by increase of l-arginine concentration but has no effect on ADMA concentrationAtherosclerosis, 2004
- ENDOTHELIAL CELL ACTIVATION IN MEN WITH ERECTILE DYSFUNCTION WITHOUT CARDIOVASCULAR RISK FACTORS AND OVERT VASCULAR DAMAGEJournal of Urology, 2004
- Asymmetrical methylarginine (ADMA) as a cardiovascular risk factorDeutsche Medizinische Wochenschrift (1946), 2004
- Lipid lowering: another method of reducing blood pressure?Journal of Human Hypertension, 2002
- Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patientsKidney International, 2002
- Asymmetric Dimethylarginine, Derangements of the Endothelial Nitric Oxide Synthase Pathway, and Cardiovascular DiseasesSeminars in Thrombosis and Hemostasis, 2000
- Noninvasive Assessment of the Digital Volume PulseHypertension, 2000
- Photoplethysmographic assessment of pulse wave reflectionJournal of the American College of Cardiology, 1999